carvacrol has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, VM; Bannister, TD; Barsamian, A; Biswas, A; Cameron, M; Choe, H; Even, Y; Jablonski, JA; Kessing, C; Mediouni, S; Richard, A; Stevenson, M; Tellinghuisen, T; Toledo, F; Tsuda, S; Valente, ST | 1 |
1 other study(ies) available for carvacrol and HIV Coinfection
| Article | Year |
|---|---|
Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.
Topics: Animals; Cholesterol; Cymenes; Drug Resistance, Viral; HeLa Cells; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Macaca mulatta; Mutation; Origanum; Plant Oils; Virus Internalization | 2020 |